Sentences with phrase «milk substitutes»

· meaningful implementation of the International Code of Marketing of Breast - Milk Substitutes and subsequent relevant Resolutions of the World Health Assembly.

Inappropriate use of breast milk substitutes may lead to infant malnutrition, serious illness, and even death in all countries.»

Now they only supply breast - milk substitutes for medical reasons,» says Julie Stufkens, who heads the New Zealand Breastfeeding Authority (NZBA), which audits the BFHI accreditation programme in the country, on behalf of, and funded by, the New Zealand Ministry of Health.

Penang, Malaysia; ICDC (International Code Documentation Centre), March 2009 IBFAN breakdown of the Code, by section IBFAN Penang (ICDC) Health Workers Guide to the Code - 11th edition, Jan 2010, completely rewritten and updated IBFAN Training Courses on the Code ICDC Focus, The Code and infant feeding in emergencies UNICEF 2007, Protecting Breastfeeding in West and Central Africa: 25 years implementing the International Code of marketing of breastmilk substitutes (authors Sokol E, Aguayo V, Clark D) WHO 1981, International code of marketing of breast - milk substitutes.

It is only since the commercial development of breast milk substitutes in the nineteenth century that health professionals have become involved in their prescription.

New Delhi, July 31: Baby food giants Heinz, Nestle and Abbott have been blatantly violating the IMS Act, (Infant Milk Substitutes, Feeding Bottles and Infant Foods Regulation of Production, Supply and Distribution Act, 1992) and Amendment Act 2003 and misleading mothers and undermining breastfeeding and natural family foods, according to the Breastfeeding Promotion Network of India (BPNI) / International Baby Food Action Network (IBFAN Asia).

Any of these milk substitutes can be used, if tolerated.

Global sales of breast - milk substitutes total US$ 44.8 billion, and are expected to rise to US$ 70.6 billion by 2019.

Encouraging women to breastfeed exclusively for six months, continue for the next six months while adding weaning foods and then as long thereafter as mother and infant choose should be standard advice, reflecting the recommendations of WHO, UNICEF, and the Innocenti Declaration.29 The national policy should follow the WHO code of marketing, which forbids marketing of breast milk substitutes on television, radio or in print materials and prohibits the giving of free formula samples.

More damaging is the common donor impulse to send infant formula or breast milk substitutes to disaster zones, undermining breastfeeding practices already in place and efforts to get new mothers to nurse.

Misuse of breast milk substitutes poses health hazards, therefore, read and follow preparation and storage instructions carefully.

«Spillover» is a term used to describe the unnecessary spread of artificial feeding among mothers who either know that they are HIV - negative or do not know their HIV status — they do not breastfeed, or they breastfeed for a short time only, or they mix - feed, because of unfounded fears about HIV, or misinformation, or the ready availability of breast - milk substitutes.

The 27th World Health Assembly in 1974 noted the general decline in breastfeeding related to different factors including the production of manufactured breast - milk substitutes and urged Member countries to review sales promotion activities on baby foods and to introduce appropriate remedial measures, including advertisement codes and legislation where necessary.

WHO has formed the Network for Global Monitoring and Support for Implementation of the International Code of Marketing of Breast - milk Substitutes and Subsequent Relevant World Health Assembly Resolutions, also known as NetCode.

To achieve BFHI accreditation, health facilities must demonstrate a rate of at least 75 % exclusive breastfeeding among mothers at discharge, adherence to the International Code of Marketing Breast - milk Substitutes and successful implementation of the Ten Steps to Successful Breastfeeding, as defined by the joint WHO / UNICEF statement, «Protecting, promoting and supporting breastfeeding: The special role of maternity services», which state that every facility providing maternity services and care for newborn infants should:

Since BFHI began, more than 152 countries around the world have implemented the initiative.9 BFHI promotes a multi-level, multi-sector approach which, together with legislation regarding statutory maternity leave and protection of the breastfeeding rights of women in the workplace and enforcement of the Code of marketing of breast milk substitutes, is essential to effectively promote, protect and support breastfeeding.6 Monitoring and re-assessment of BFHI facilities are important as the initiative expands.

Breastfeeding is an unequalled way of providing ideal food for the healthy growth and development of infants1, providing protection from morbidity and mortality due to infectious diseases2 and chronic diseases later in life.3 Exclusive breastfeeding is recommended, starting within one hour of birth and for the first 6 months of life, with continued breastfeeding to 2 years of age and beyond.4 However, rates of initiation, exclusive breastfeeding and breastfeeding duration have fallen since the widespread introduction and promotion of breast - milk substitutes.5 Successful breastfeeding depends on a number of factors, including a re-normalisation of breastfeeding as the infant feeding method of choice through antenatal counselling and education and breastfeeding support to prevent and resolve breastfeeding difficulties.

Assessing and accrediting birthing facilities that meet those standards and follow the International Code of Marketing of Breast - milk Substitutes; and

Governments should review progress in national implementation of the International Code of Marketing of Breast milk Substitutes, and consider new legislation or additional measures as needed to protect families from adverse commercial influences.

The specific Mead Johnson Nutrition products shown on this website may not be available for distribution or sale outside the U.S. Mead Johnson Nutrition endorses the aim of the World Health Organization (WHO) International Code of Marketing of Breast - milk Substitutes in developing countries, including standards for product integrity, labeling, distribution, and promotion.

This includes increasing maternity leave, strengthening the quality of care in maternity facilities to include lactation counselling, and protecting against aggressive marketing of breast - milk substitutes so that mothers can gain confidence in their breastfeeding abilities.

Whilst the UK has signed up to «the Code», today's report highlights the fact that aggressive and inappropriate marketing of breast - milk substitutes, and other food products that compete with breastfeeding, continues to undermine efforts to improve breastfeeding rates.

HIV Medicine DOI: 10.1111/j.1468-1293.2011.00918.x IBFAN - Asia Position Statement on HIV and Infant Feeding, 13 October 2008 South African Tshwane Declaration on breastfeeding, S Afr J Clin Nutr 2011; 24 (4) UNAIDS 2010, Strategy Getting to Zero, UNAIDS Strategy 2011 — 2015 UNAIDS 2010, Agenda for Accelerated Country Action for Women, Girls, Gender Equality and HIV, 2010 - 2014 UNAIDS 2011, Countdown to Zero: Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011 - 2015 UNAIDS 2011 Press Release, 9 June, World leaders launch plan to eliminate new HIV infections among children by 2015 UNICEF Convention on the Rights of the Child UNICEF 2010, Facts for Life UNICEF 2011, Programming Guide, Infant and Young Child Feeding, 26 May 2011 WHO / UNICEF 2003, Global strategy for infant and young child feeding WHO 2007, Evidence on the long - term effects of breastfeeding: systematic reviews and meta - analysis WHO, UNAIDS, UNICEF 2009, Towards universal access: scaling up priority HIV / AIDS interventions in the health sector: progress report 2009 WHO 2009, Women and health, Today's evidence tomorrow's agenda WHO 2009, Acceptable medical reasons for use of breast - milk substitutes WHO 2009, Rapid advice: use of antiretroviral drugs for treating pregnant womenand preventing HIV Infection in infants WHO 2009, Rapid advice: revised WHO principles and recommendations on infant feeding in the context of HIV WHO 2010, Priority Interventions — HIV / AIDS prevention, treatment and care in the health sector WHO 2010, Guidelines on HIV and infant feeding: Principles and recomendations for infant feeding in the context of HIV and a summary of evidence WHO 2010, Annexure 7b to Guidelines on HIV and infant feeding.

Breastfeeding research continues to assess prevalence, HIV transmission, pharmacology, costs, benefits, immunology, contraindications, and comparisons to synthetic breast milk substitutes.

[204] The initiative has two core tenets: the Ten Steps to Successful Breastfeeding and the International Code of Marketing of Breast - milk Substitutes.

Effects of brief exposure to water, breast - milk substitutes, or other liquids on the success and duration of breastfeeding: a systematic review

Hospitals and birthing centers wishing to attain Baby - Friendly designation must abide by the provisions of the International Code of Marketing of Breast - Milk Substitutes.

Some 66 delegates at the AGM of the Royal College of Paediatrics and Child Health (RCPCH) voted in favour of a motion that urged it to «decline any commercial transactions or any other kind of funding or support» from all companies that market breast milk substitutes.

Significant provisions of this code prevent hospitals and birthing centers from accepting free or low - cost infant formula, providing free samples of infant formula to families, or advertising breast - milk substitutes.

Provisions of the International Code of Marketing of Breast - Milk Substitutes require:

Increased global demand for imported breast milk substitutes (infant formula, follow - on formula and toddler milks) in Asia, particularly China, and food safety recalls have led to shortages of these products i...

What is disturbing is the goal of Mead Johnson to increase its market share outside the US - where legislation and enforcement of laws protecting breastfeeding and the implementation of the International Code of Marketing Breast - milk Substitutes is not well established.

One of the tenets of the Baby - Friendly Hospital Initiative is that the marketing of breast - milk substitutes, including infant formula, discourages mothers from initiating and / or exclusively breastfeeding their infants.

Supplementation with breast milk substitutes when mom's own breast milk is not enough is in fact an important part of the treatment regimen of a hyperbilirubinemic newborn as enteric excretion is the primary mode of bilirubin elimination.

The section «Developments related to Nestlé since 2006» erroneously gives the impression that Nestlé was admitted to FTSE4Good after strengthening its policy as it states: «In 2010 Nestlé revised its policy and Instructions for Implementation of the WHO International Code of Marketing of Breast - milk Substitutes.

Is unimpeded marketing for breast milk substitutes responsible for the decline in breastfeeding in the Philippines?

In this context, the EU Action Plan recognised the continuous importance of the World Health Organisation (WHO) International Code of Marketing of Breast - milk Substitutes, on which Directive 2006 / 141 / EC was based.

The WHO Code, adopted by the 34th World Health Assembly, aims at contributing to the provision of safe and adequate nutrition for infants, by the protection and promotion of breast - feeding, and by ensuring the proper use of breast - milk substitutes.

An Expert Committee on Breast Milk Substitutes advises on the criteria and the inclusion or exclusion of companies and includes the Methodist Church CFB, despite it having a conflict of interest as an investor in Nestlé (note 1).

Considers that the delegated regulation does not contain sufficient provisions to prevent unfair competition with breastfeeding and therefore undermines the International Code of Marketing of Breast - Milk Substitutes and subsequent WHA Resolutions and MS efforts to implement them effectively;

The Code is a set of recommendations to regulate the marketing of breast - milk substitutes, feeding bottles and teats.

A number of studies strongly suggest a direct correlation between marketing strategies for follow - up formulae, and perception and subsequent use of these products as breast - milk substitutes.

Write Today's Parent and ask them — once and for all — to stop aiding and abetting the infant formula industry by running ads that violate the International Code of Marketing of Breast - milk Substitutes and Canada's Food and Drugs regulations on health claims for infant formula as well as consumer protection laws prohibiting misleading advertising.

1 The Codex Code of Ethics for International Trade in Food calls on Member States to: «make sure that the international code of marketing of breast milk substitutes and relevant resolutions of the World Health Assembly (WHA) setting forth principles for the protection and promotion of breast - feeding be observed.»

We will support in full the implementation of the WHO International Code of Marketing of Breast - milk Substitutes and the subsequent WHA resolutions.

18 Article 1, International Code of Marketing of Breast - milk Substitutes, World Health Organization, Geneva, 1981.

Most recently, China's government has also begun to provide subsidies ($ 4.9 bn) for the production of breast milk substitutes to compete against foreign brands [15], [16] instead of supporting breastfeeding.

Its aim is «to contribute to the provision of safe and adequate nutrition for infants, by the protection and promotion of breast - feeding, and by ensuring the proper use of breast - milk substitutes, when these are necessary, on the basis of adequate information and through appropriate marketing and distribution».18

Marketing of breast - milk substitutes contributes to low rates of exclusive breastfeeding and suboptimal breastfeeding.

Nestle claims to abide by the WHO's International Code of Marketing of Breast - Milk Substitutes, which explicitly forbids formula promotion through the health care system.